Literature DB >> 11927015

Close association between Fas ligand (FasL; CD95L)-positive tumor-associated macrophages and apoptotic cancer cells along invasive margin of colorectal carcinoma: a proposal on tumor-host interactions.

Junichi Sugita1, Haruo Ohtani, Takayuki Mizoi, Kazuya Saito, Kenichi Shiiba, Iwao Sasaki, Seiki Matsuno, Hideo Yagita, Masaaki Miyazawa, Hiroshi Nagura.   

Abstract

Anti-tumor immune responses are considered to be one of the key host reactions in human colorectal cancer, with T cells as important effector cells. For the induction of tumor-specific immunity, processing of cancer cells and priming of T cells by antigen-presenting cells are important. The present study was designed to clarify the relationship between Fas ligand (FasL; CD95L) expression and apoptotic cancer cells. Immunohistochemistry using frozen sections taken from 58 patients with colorectal cancer revealed that stromal cells composed mainly of tumor-associated macrophages expressed FasL, leaving cancer cells negative for FasL. These macrophages were abundantly distributed along the invasive margin. In situ hybridization revealed that these macrophages as well as cancer cells expressed FasL mRNA, whereas macrophages in the normal colon mucosa rarely expressed FasL. Apoptotic cancer cells recognized by monoclonal antibody M30 CytoDEATH were localized not only in cancer cell nests, but also in the stroma along the invasive margin showing a dissociated pattern, which was particularly evident in the areas of FasL+ macrophages. Furthermore, these macrophages, phenotypically similar to dendritic cells, occasionally contained M30+ apoptotic cancer cells in the cytoplasm. Clinicopathologic analyses in 123 cases revealed 1) a positive correlation between the degree of dissociated M30+ apoptotic cancer cells and the number of macrophages along the invasive margin and 2) an inverse association between the degree of dissociated M30+ apoptotic cancer cells and the occurrence of hematogenous metastasis after surgical resection of the primary tumor. In conclusion, the present study shows the importance of FasL+ activated macrophages as one of the host defense mechanisms against cancer cell spread in human colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927015      PMCID: PMC5926973          DOI: 10.1111/j.1349-7006.2002.tb02175.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  36 in total

1.  Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.

Authors:  N P Restifo
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

2.  Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation.

Authors:  P A Kiener; P M Davis; B M Rankin; S J Klebanoff; J A Ledbetter; G C Starling; W C Liles
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

3.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.

Authors:  B Lowin; M Hahne; C Mattmann; J Tschopp
Journal:  Nature       Date:  1994-08-25       Impact factor: 49.962

4.  Antitumor effect of locally produced CD95 ligand.

Authors:  K Seino; N Kayagaki; K Okumura; H Yagita
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

5.  Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; D Roche; J Kelly; J K Collins; F Shanahan
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

6.  Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.

Authors:  N Favre-Felix; A Fromentin; A Hammann; E Solary; F Martin; B Bonnotte
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

7.  Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis.

Authors:  K Saito; S Takeha; K Shiba; S Matsuno; T Sorsa; H Nagura; H Ohtani
Journal:  Int J Cancer       Date:  2000-04-01       Impact factor: 7.396

8.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

Authors:  Y Naito; K Saito; K Shiiba; A Ohuchi; K Saigenji; H Nagura; H Ohtani
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

9.  Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes.

Authors:  S B Brown; J Savill
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

Review 10.  Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells.

Authors:  P D Greenberg
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

View more
  16 in total

1.  Tissue expression of the proteins fas and fas ligand in colorectal cancer and liver metastases.

Authors:  Stylianos Kykalos; Spuridon Mathaiou; Anastasios J Karayiannakis; Dimitris Patsouras; Maria Lambropoulou; Constantinos Simopoulos
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 2.  Immune cell interplay in colorectal cancer prognosis.

Authors:  Samuel E Norton; Kirsten A Ward-Hartstonge; Edward S Taylor; Roslyn A Kemp
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

3.  Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.

Authors:  Fei Yang; Yinxiang Wei; Zhijian Cai; Lei Yu; Lingling Jiang; Chengyan Zhang; Huanmiao Yan; Qingqing Wang; Xuetao Cao; Tingbo Liang; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2014-04-28       Impact factor: 11.530

Review 4.  Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.

Authors:  Bruno Christian Koehler; Dirk Jäger; Henning Schulze-Bergkamen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

5.  Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.

Authors:  Michael J Cavnar; Simon Turcotte; Steven C Katz; Deborah Kuk; Mithat Gönen; Jinru Shia; Peter J Allen; Vinod P Balachandran; Michael I D'Angelica; T Peter Kingham; William R Jarnagin; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2017-02-17       Impact factor: 5.344

6.  Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.

Authors:  Marco Erreni; Alberto Mantovani; Paola Allavena
Journal:  Cancer Microenviron       Date:  2010-09-17

Review 7.  Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.

Authors:  P Allavena; A Mantovani
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

8.  Tumor-associated macrophages (TAMs) depend on Shp2 for their anti-tumor roles in colorectal cancer.

Authors:  Saisai Wang; Yuanyuan Yao; Huixia Li; Gang Zheng; Sen Lu; Wenbin Chen
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

9.  Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages.

Authors:  Bisweswar Nandi; Mia Shapiro; Mehmet K Samur; Christine Pai; Natasha Y Frank; Charles Yoon; Rao H Prabhala; Nikhil C Munshi; Jason S Gold
Journal:  Oncoimmunology       Date:  2016-05-24       Impact factor: 8.110

10.  The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer.

Authors:  Qiang Zhou; Rui-Qing Peng; Xiao-Jun Wu; Qing Xia; Jing-Hui Hou; Ya Ding; Qi-Ming Zhou; Xing Zhang; Zhi-Zhong Pang; De-Sen Wan; Yi-Xin Zeng; Xiao-Shi Zhang
Journal:  J Transl Med       Date:  2010-02-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.